Literature DB >> 30504385

Analysis of Malignant Melanoma Cell Lines Exposed to Hypoxia Reveals the Importance of PFKFB4 Overexpression for Disease Progression.

Sonia E Trojan1, Monika Piwowar2, Barbara Ostrowska1, Piotr Laidler1, Kinga A Kocemba-Pilarczyk3.   

Abstract

BACKGROUND/AIM: Most melanomas develop in hypoxic conditions. Since hypoxia via HIF-1 induces glycolysis, a process essential for malignant melanoma growth/survival, the goal of this study was to analyze the influence of hypoxia on the expression of HIF-1 target genes involved in glucose metabolism.
MATERIALS AND METHODS: The response of melanoma cell lines to hypoxic conditions was analyzed by RT-PCR and western blotting. A Kaplan-Meier survival analysis for patients with high and low expression level of PFKFB4 was performed. Further analysis of patients' data was performed using the R/Bioconductor environment.
RESULTS: Induction of PFKFB4 gene expression can be considered a crucial mechanism behind glycolysis enhancement in hypoxic melanoma cells. Analysis of a publicly available database revealed that high PFKFB4 expression contributes to poor prognosis of melanoma patients.
CONCLUSION: Currently available anti-melanoma therapeutic strategies may significantly benefit from agents targeting PFKFB4 activity. Copyright
© 2018, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  HIF-1; Hypoxia; PFKFB4; malignant melanoma

Mesh:

Substances:

Year:  2018        PMID: 30504385     DOI: 10.21873/anticanres.13044

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  PFKFB4 as a promising biomarker to predict a poor prognosis in patients with gastric cancer.

Authors:  Fang Wang; Xiaoting Wu; Yajun Li; Xiangmei Cao; Cao Zhang; Yujing Gao
Journal:  Oncol Lett       Date:  2021-02-17       Impact factor: 2.967

Review 2.  Hypoxia and Extracellular Acidification as Drivers of Melanoma Progression and Drug Resistance.

Authors:  Ewelina Dratkiewicz; Aleksandra Simiczyjew; Justyna Mazurkiewicz; Marcin Ziętek; Rafał Matkowski; Dorota Nowak
Journal:  Cells       Date:  2021-04-09       Impact factor: 6.600

3.  The influence of PFK-II overexpression on neuroblastoma patients' survival may be dependent on the particular isoenzyme expressed, PFKFB3 or PFKFB4.

Authors:  Sonia E Trojan; Michał J Markiewicz; Katarzyna Leśkiewicz; Kinga A Kocemba-Pilarczyk
Journal:  Cancer Cell Int       Date:  2019-11-14       Impact factor: 5.722

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.